相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Key Points to Consider When Evaluating Andexxa for Formulary Addition
Harry Peled et al.
NEUROCRITICAL CARE (2020)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Novel Whole Blood Point-of-Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins
Jack Ansell et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and metaanalysis
Raghavendra Charan P. Makam et al.
PLOS ONE (2018)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
Jack E. Ansell et al.
THROMBOSIS AND HAEMOSTASIS (2017)
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Nadine Shehab et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
Jack E. Ansell et al.
THROMBOSIS RESEARCH (2016)
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
Chatree Chai-Adisaksopha et al.
BLOOD (2014)
Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
Jack E. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
分享论文
